Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

Although RSV often presents initially with common cold-like symptoms, it can progress to more severe respiratory problems.

From today, February 3, pregnant women in Australia will be eligible for a free RSV vaccine under the National Immunisation ...

“Watched my baby with a tube down his throat for eight days and wasn’t sure if I was ever going to hold him again,” Elliot’s ...

Those most at risk from RSV include babies under 6 months old, young children who were born prematurely, and adults over ...

Health officials are urging older adults to get vaccinated against respiratory syncytial virus (RSV). NHS England announced ...

More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.

A new NHS text message campaign is set to encourage RSV vaccinations. Starting on February 10, the campaign targets those ...

MORE than one million people in England are being urged to get a life-saving new vaccine. It protects against respiratory syncytial virus (RSV) – a cold-like illness that can make some ...

NHS England appeals for 1.3 million eligible people to come forward for a new jab against respiratory syncytial virus (RSV) ...